Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT07757880
RecruitingNCT07757880ClinicalTrials.gov record

Randomized Evaluation of Operating Room Extubation After Cardiac Surgery

Cardiac Surgery

THE QUICK READ

What this study involves

The registry says this study is recruiting. Individual locations may have different availability.

Study type
Interventional
Phase
Not applicable
Age range
18 years - Not specified
Sex eligible
All sexes
Healthy volunteers
Not accepted
Participants
120 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

We are studying whether waking patients up and removing the breathing tube (also known as "extubation") in the operating room after cardiac surgery improves postoperative recovery without causing harm.

Read the full description

This is a pragmatic, randomized controlled trial comparing OR extubation versus ICU extubation among adults undergoing elective cardiac surgery.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • Adults (age 18+) scheduled for elective cardiac surgery requiring cardiopulmonary bypass
  • Low perioperative risk defined as STS Predicted Risk of Mortality (PROM) ≤ 3% based on the latest STS Adult Cardiac Surgery Database (ACSD) Risk Calculator
  • Deemed appropriate for OR extubation preoperatively by the attending cardiac surgeon
  • Able to provide informed consent

Exclusion Criteria:

  • Underlying pulmonary disease requiring use of home supplemental oxygen
  • Pre-capillary pulmonary hypertension (mPAP ≥ 25 mmHg or PVR \> 2 Wood units) on most recent right heart catheterization for any patient for which there is suspicion for pulmonary hypertension at the time of preoperative evaluation
  • Preoperative right ventricular dysfunction greater than mild on most recent echocardiogram
  • BMI ≥ 35
  • Obstructive sleep apnea with home CPAP or biPAP use or recommended use
  • Neuromuscular disease associated with respiratory muscle weakness including myasthenia gravis, Lambert-Eaton myasthenic syndrome, or muscular dystrophy
  • Airway abnormalities including tracheostomy, history of difficult mask ventilation, history of difficult intubation requiring fiberoptic rescue or multiple (\>2) attempts, known anatomic abnormalities including limited mouth opening (\< 3cm), severe micrognathia, tracheal stenosis, or tracheal compression due to mass or goiter

We will also exclude patients undergoing the following procedures:

  • Transplant surgery
  • Pulmonary thromboendarterectomy
  • Implantation of mechanical circulatory support including LVAD, Impella, intra-aortic balloon pump, RVAD, or ECMO
Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Random assignment
Masking
Double masked
OR extubation

Extubation in the operating room (OR) at the conclusion of cardiac surgery

Procedure: OR extubation

ICU extubation

Extubation in the intensive care unit (ICU) within 6 hours of leaving the OR

Procedure: ICU extubation

OR extubation PROCEDURE

Immediate extubation in the operating room (OR) at the conclusion of cardiac surgery

ICU extubation PROCEDURE

Extubation in the intensive care unit (ICU) within 6 hours of leaving the operating room after cardiac surgery

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Hierarchical composite endpoint, ordered by clinical priority

Time frame: 15 days postoperatively

1. Death by postoperative day 15;
2. Unplanned reintubation or cumulative mechanical ventilation \> 12 hours from OR exit, assessed through 48 hours postoperatively;
3. Days at home through postoperative day 15 (DAH-15). DAH-15 will be measured from the time of post-operative ICU admission and will subtract any time spent in a hospital (index hospitalization or readmission), rehabilitation center, or nursing facility.

Secondary measures

Postoperative ICU length of stay

Time frame: 30 days

Cumulative length of stay (hours) in an intensive care unit (ICU) following cardiac surgery

Postoperative hospital length of stay

Time frame: 30 days

Length of index hospitalization (hours) following cardiac surgery

Use of non-invasive respiratory support

Time frame: 48 hours

Use of non-invasive respiratory support such as biPAP, CPAP, or high flow oxygen after OR exit

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (2)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

2 locations

Massachusetts General HospitalBoston, Massachusetts, United StatesRecruiting
Brigham and Women's HospitalBoston, Massachusetts, United StatesNot yet recruiting
Chinyere Archie, MBBSCONTACTcarchie1@bwh.harvard.edu617-732-8210
Margaret Connolly, MDCONTACTmrconnolly@mgb.org
View location on map ↗

Study team and timeline

Lead sponsor
Massachusetts General Hospital
Study start
Nov 9, 2026 Estimated
Primary completion
2027-05 Estimated
Study completion
2027-06 Estimated
First posted
Aug 11, 2026 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

Lauren Gibson, MDCONTACTlegibson@mgh.harvard.edu617-726-3030
Jordan Bloom, MD, MPHCONTACTjpbloom@mgh.harvard.edu617-643-6058
Official study title

Randomized Evaluation of Operating Room Extubation Versus Intensive Care Unit Extubation After Cardiac Surgery

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026